Related Experiment Video
Updated: May 22, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Novel mutation in potassium channel related gene KCTD7 and progressive myoclonic epilepsy
Birgit Krabichler1, Kevin Rostasy, Matthias Baumann
1Department of Medical Genetics, Molecular and Clinical Pharmacology, Division of Human Genetics, Medical University Innsbruck, Austria.
Insights
This study identifies a novel mutation in the KCTD7 gene causing progressive myoclonic epilepsy (PME). This finding suggests KCTD7 mutations are a recurrent cause of this severe neurological disorder.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Progressive myoclonic epilepsy (PME) is a group of rare neurological disorders.
- PME presents with myoclonus, seizures, and progressive neurological decline.
- Early-onset PME often shows resistance to therapy and severe developmental delay.
Observation:
- A 6-year-old boy with early-onset, therapy-resistant PME and developmental delay was studied.
- Genome-wide linkage analysis pinpointed candidate regions for the genetic cause.
- The potassium channel tetramerization domain containing 7 (KCTD7) gene was identified as a strong candidate.
Findings:
- A novel homozygous missense mutation (p.R94W) was discovered in exon 2 of the KCTD7 gene.
- This mutation was found in a highly conserved segment of the gene.
- This is the second reported family with PME linked to KCTD7 mutations.
Implications:
- KCTD7 mutations represent a significant genetic cause of PME.
- Further research into KCTD7's role in epilepsy is warranted.
- Genetic diagnosis of PME may be improved by screening KCTD7.
Abstract:
Progressive myoclonic epilepsy (PME) is a heterogeneous group of epilepsies characterized by myoclonus, seizures and progressive neurological symptoms. The index patient was a 6-year old boy showing early-onset therapy resistant PME and severe developmental delay. Genome-wide linkage analysis identified several candidate regions. The potassium channel tetramerization domain containing 7 gene (KCTD7) in the 7q11.21 linkage region emerged as a suitable candidate. Sequence analysis revealed a novel homozygous missense mutation (p.R94W) in a highly conserved segment of exon 2. This is the second family with PME caused by KCTD7 mutations, hence KCTD7 mutations might be a recurrent cause of PME.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Animal Mitochondrial Genetics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.